MedTrace Logo

Acute Studies on the Glycemic Index After Intake of Different Sorts of Barley in Subjects With Type 2 Diabetes

NCT04646746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-05-06

No results posted yet for this study

Summary

In a series of double-blinded randomized cross-over acute studies, the investigators want to study the effects of different types of barley on the glycemic index (GI) in subjects with type 2 diabetes.

The most common type of barley in Denmark is with rind and demands processing before use. Processing may remove important nutrients from the barley. Some of the original antiquity barley has a loose rind (nude barley), that falls off during harvesting, and thereby reduces the need for processing. The investigators want to study how this ancient type of barley affects GI.

Furthermore, some of the investigators collaborative partners have made it possible to increase the amount of amylose in regular barley by genetic modification. The investigators want to study the effect on GI of this new type of modified barley.

Conditions

Interventions

DIETARY_SUPPLEMENT

100% wheat

100 g of bread backed with 100% wheat

DIETARY_SUPPLEMENT

50% nude barley and 50% wheat

100 g of bread backed with 50% nude barley and 50% wheat

DIETARY_SUPPLEMENT

75% nude barley and 25% wheat

100 g of bread backed with 75% of nude barley and 25% wheat

DIETARY_SUPPLEMENT

50% gene-modified high-amylose barley and 50% wheat

100 g of bread backed with 50% gene-modified high-amylose barley and 50% wheat

Sponsors & Collaborators

  • Innovation Fund Denmark

    collaborator INDIV

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Mette B Larsen, MD, PhD · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-08
Primary Completion
2021-10-29
Completion
2021-10-29

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04646746 on ClinicalTrials.gov